Stanford University
Showing 20,771-20,780 of 36,305 Results
-
Apurva Mehta
Senior Scientist, SLAC National Accelerator Laboratory
BioI am a materials scientist with three decades of experience unraveling the molecular-scale processes that govern the functionality, aging, and failure of complex materials and devices. Over this time, advanced characterization methods have undergone a revolutionary transformation, driven by the emergence of brighter sources—from synchrotrons and X-ray free-electron lasers to MeV accelerator-based electron sources—paired with faster and larger-area detectors. While the depth and precision of measurements have vastly improved, the explosion of raw data now poses a significant challenge, making it increasingly difficult to extract meaningful insights them.
Recognizing this growing challenge, I have devoted the last decade to harnessing the power of emerging machine learning and artificial intelligence techniques to find breakthroughs. My focus has been on not only accelerating the extraction of knowledge from intricate, multi-dimensional, and often noisy measurements but also on making data collection smarter. By integrating these cutting-edge technologies, I aim to transform how we approach material science and deepen our understanding of material behavior and device performance. -
Arnav Mehta, MD, PhD
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioDr. Mehta is a board-certified, fellowship-trained medical oncologist at the Stanford Medicine Cancer Center. He is also an adjunct clinical assistant professor in the gastrointestinal (GI) oncology group of the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Mehta specializes in gastrointestinal cancer, with a particular focus on pancreatic and gastric cancers. He also treats colorectal cancers. His treatment specialties include immunotherapy — helping a patient’s immune system fight cancer — and targeted therapies, which send cancer-fighting drugs to specific cancer cell molecules.
His research interests include understanding why GI cancers resist treatments and identifying new ways to treat these tumors. In particular, he is interested in GI tumor immunology, which focuses on directing a person’s immune system to help destroy cancer cells. He also has a special interest in tumor plasticity, which represents the ability of a tumor cell to evolve and develop resistance to therapies.
Dr. Mehta has earned research awards and grants from organizations including the American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and the National Institutes of Health.
Dr. Mehta has published in many peer-reviewed journals, including Nature, Nature Genetics, Nature Immunology, Nature Medicine, Nature Cancer, Cancer Discovery and Immunity. He has written book chapters on subjects including esophageal and gastric cancer. He has also presented his research on topics including tumor immunology and pancreatic cancer at dozens of symposia and meetings around the country.
Dr. Mehta is a member of the AACR and ASCO.
